Open AccessMild Cognitive Impairment with a High Risk of Progression to Alzheimer’s Disease Dementia (MCI-HR-AD): Effect of Souvenaid® Treatment on Cognition and 18F-FDG PET Scans
Author(s) -
María Sagrario Manzano Palomo,
Belén Anaya Caravaca,
M.A. Balsa Bretón,
Sergio MuñizCastrillo,
Asuncion de la Morena Vicente,
Eduardo Castro Arce,
María Teresa Alves Prez
Publication year - 2019
Publication title -
journal of alzheimer's disease reports
Language(s) - English
Resource type - Journals
ISSN - 2542-4823
DOI - 10.3233/adr-190109
Subject(s) - dementia , medicine , neurology , memory clinic , neuropsychology , cognition , neurodegeneration , cohort , disease , pediatrics , psychiatry
Previous studies have shown that Souvenaid (medical food) can have benefits on memory, cognition, and function in early Alzheimer's disease (AD) and mild cognitive impairment (MCI).